Gene Transfer

Kit speeds transfer into hard-to-transfect cell lines, company says

Published in Gene Therapy Weekly, June 27th, 2002

With its new "Cell Line Optimization Nucleofector Kit", researchers can now optimize the transfection of previously hard-to-transfect cell lines within 2 weeks, according to amaxa.

"Compared with conventional methods, our product saves up to 70% of time required for such an optimization process", explained Wolfgang Kintzel, vice president Marketing at amaxa. "With our new optimization kit we are now able to address another key segment in the gene transfer market."

By launching the new kit for hard-to-transfect cell lines amaxa closes the gap between standard cell lines and primary cells. The Nucleofector technology can now be used for the complete...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2002-06-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry